Literature DB >> 217400

Effect of prostaglandins and hormones on cyclic AMP formation in rat hepatomas and liver tissue.

G O Brønstad, T Christoffersen, E J Johansen, I Oye.   

Abstract

The formation of cyclic AMP was studied in normal liver, subcutaneous hepatomas derived from MH1C1 cells, and premalignant liver and primary hepatomas induced by the carcinogens 2-acetylaminofluorene (AAF) and 4-dimethylamino-azobenzene (DAB). While only very slight effects of prostaglandins (PG) were seen in slices of normal liver, all the hepatomas responded strongly to PGE1 and PGE2. The hepatomas also had increase PGE1-sensitive adenylate-cyclase activity. PGF1alpha and PGF2alpha did not increase the cAMP level significantly either in the liver or in the hepatomas. During AAF carcinogenesis the response to PGE1 increased slightly during the carcinogen feeding, and was greatly elevated only in the fully developed hepatomas. This is in contrast to the increase in adrenalin response seen during carcinogenesis, which starts much earlier, and reaches a peak value within 8--10 weeks. It is concluded that various hepatomas have elevated responsiveness to PGE1 and PGE2 as well as to adrenalin, but the course of change in the tissues' ability to respond to these agents during carcinogenesis is very different.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 217400      PMCID: PMC2009833          DOI: 10.1038/bjc.1978.281

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  29 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Present paradoxes in the environmental control of hepatic proliferation.

Authors:  H L Leffert; K S Koch; B Rubalcava
Journal:  Cancer Res       Date:  1976-11       Impact factor: 12.701

Review 3.  Role of cyclic nucleotides in cell growth and differentiation.

Authors:  D L Friedman
Journal:  Physiol Rev       Date:  1976-10       Impact factor: 37.312

4.  Sonication as a tool for the study of adenylyl cyclase activity.

Authors:  S B Achar; S Strada; R B Sanders; W J Pledger; W J Thompson; G A Robison
Journal:  J Cyclic Nucleotide Res       Date:  1977-06

5.  Comparison of cyclic adenosine 3':5'-monophosphate and cyclic guanosine 3':5'-monophosphate levels, cyclases, and phosphodiesterases in Morris hepatomas and liver.

Authors:  R A Hickie; W J Thompson; S J Strada; B Couture-Murillo; H P Morris; G A Robison
Journal:  Cancer Res       Date:  1977-10       Impact factor: 12.701

6.  Activity and hormone responsiveness of adenyl cyclase during induction of tumors in rat liver with 3'-methyl-4-dimethylaminoazobenzene.

Authors:  H Boyd; C J Louis; T J Martin
Journal:  Cancer Res       Date:  1974-07       Impact factor: 12.701

7.  Hepatic adenyl cyclase: alterations in hormone response during treatment with a chemical carcinogen.

Authors:  T Christoffersen; J Morland; J B Osnes; K Elgjo
Journal:  Biochim Biophys Acta       Date:  1972-09-15

8.  Studies on plasma membranes. XIV. Adenyl cyclase in plasma membranes isolated from rat and mouse livers and hepatomas, and its hormone sensitivity.

Authors:  P Emmelot; C J Bos
Journal:  Biochim Biophys Acta       Date:  1971-10-12

9.  A highly sensitive adenylate cyclase assay.

Authors:  Y Salomon; C Londos; M Rodbell
Journal:  Anal Biochem       Date:  1974-04       Impact factor: 3.365

10.  Establishment of a clonal strain of hepatoma cells which secrete albumin.

Authors:  U I Richardson; A H Tashjian; L Levine
Journal:  J Cell Biol       Date:  1969-01       Impact factor: 10.539

View more
  3 in total

Review 1.  Growth-related alterations during liver carcinogenesis: effect of promoters.

Authors:  P O Seglen; P Gerlyng
Journal:  Environ Health Perspect       Date:  1990-08       Impact factor: 9.031

2.  Human hepatocellular cancers show decreased prostaglandin E1 binding capacity.

Authors:  I Virgolini; H Sinzinger; C Müller; M Hermann
Journal:  Br J Cancer       Date:  1989-03       Impact factor: 7.640

3.  Decrease of prostaglandin I2 binding sites in thyroid cancer.

Authors:  I Virgolini; M Hermann; H Sinzinger
Journal:  Br J Cancer       Date:  1988-11       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.